Omada Health is a U. S. -based virtual-care provider offering clinically validated programs for chronic conditions like cardiometabolic disease, musculoskeletal care, and behavioral health—delivered digitally between doctor visits. .
Omada Health stock last closed at $15.29, up 4.87% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Health Information Services industry by N/A percentage points. Omada Health stock is currently +48.74% from its 52-week low of $10.28, and -46.16% from its 52-week high of $28.40.
As of May 1, 2026, there are 58.93M shares of OMDA outstanding. The market cap of OMDA is $900.97M. In the last 24 hours, 1.57M OMDA shares were traded.
You will need a brokerage account to access the NASDAQ market and buy OMDA shares.
Based on our analysis, eToro is the best brokerage. Here's why:
Get $10 towards your stock purchase by creating an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've picked your brokerage, you need to fill out some personal info so you can invest in OMDA today.
Now that you've finished signing up on the best free stock trading app, your next step is to transfer the money for your investment:
Watch the video below to see the process of transferring money into your investment account.
Once you have selected the best place to buy Omada Health stock, it's critical to analyze their stock before you buy, so you truly comprehend the risk and opportunity.
WallStreetZen was designed to help average investors perform more in-depth fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on OMDA's stock page.
You can use a variety of different financial metrics, analyses, models, and charts to gauge OMDA's intrinsic value.
Using relative valuations methods:
You can access more valuation research on OMDA's stock here.
Out of 10 Wall Street analysts who give ratings on OMDA, the consensus analyst rating on Omada Health is a Strong Buy
It's important to keep in mind that analyst ratings are not recommendations, nor are they financial advice.
Sean Dodge, a top 32% analyst from BMO Capital maintains OMDA with a buy rating and lowers their OMDA price target from $27.00 to $18.00, on Mar 6, 2026.
Craig Hettenbach, a top 24% analyst from Morgan Stanley maintains OMDA with a strong buy rating and lowers their OMDA price target from $32.00 to $30.00, on Mar 6, 2026.
Saket Kalia, a top 6% analyst from Barclays maintains OMDA with a strong buy rating and raises their OMDA price target from $17.00 to $18.00, on Mar 6, 2026.
Barclays's Saket Kalia raised their price target on Omada Health (NASDAQ: OMDA) by 5.9% from $17 to $18 on 2026/03/06. The analyst maintained their Strong Buy rating on the stock.
Omada Health reported its Q4 and FY 2025 earnings.
Raising their price target, Kalia pointed to the quarter's accelerated revenue growth and membership, both attributable to strength in GLP-1 and multi-condition adoption.
Omada Health's FY 2026 revenue guide leaves room for upside, the analyst added.
Omada Health reported:
For Q4 2025:
For FY 2025:
For FY 2026, management guided:
CEO Sean Duffy commented: “Our 2025 performance reflects a pivotal year for Omada, marked by strong growth, important profitability milestones, and continued momentum across our business.
“We demonstrated GLP‑1 companion support innovation, advanced our member‑facing AI capabilities, and introduced meaningful program expansions—all designed to support our members in achieving durable health improvements and serving as a foundation for progress toward our long‑term mission to bend the curve of chronic disease.”
Ryan MacDonald, a bottom 1% analyst from Needham reiterates OMDA with a buy rating and maintains their OMDA price target from $28.00 to $28.00, on Jan 22, 2026.
Stan Berenshteyn, a bottom 4% analyst from Wells Fargo initiates coverage on OMDA with a hold rating and announces their OMDA price target of $17.00, on Jan 9, 2026.
You can dive deeper into what analysts are saying on the Omada Health stock forecast page.
Last year, OMDA revenue was $260.21M. During the last 2 year, OMDA's revenue has grown by 45.58% per year. This was faster than the Health Information Services industry average of 33.23%.
You can analyze OMDA's earnings and revenue performance here.
In the last 12 months, executives and large shareholders at OMDA have sold more shares than they have bought.
Weili Shao, President of OMDA, was the latest OMDA insider to sell. They sold $35,945.27 worth of OMDA shares on Apr 8, 2026.
Dig into more about who owns OMDA stock here.
No, Omada Health doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other traders have to say.
You have two primary order types:
Click the Open button and eToro will place your order.
If you want more assistance investing in stocks on eToro, click the helpful video below:
Now that you own some OMDA stock, you'll want to stay up-to-date on your new investment.
Create a watchlist to keep track of your OMDA stock.
To reiterate, here are the 6 steps to buy Omada Health stock:
If you are looking for a online brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to keep an eye on your new investment in Omada Health, click the button below.